[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":2869069.0,"NotesPayableCurrent_0_Q3_USD":631400.0,"OperatingCostsAndExpenses_1_Q3_USD":2061256.0,"OperatingCostsAndExpenses_3_Q3_USD":5036086.0,"OperatingIncomeLoss_1_Q3_USD":-2061256.0,"OperatingIncomeLoss_3_Q3_USD":-5036086.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":7893619.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":3519420.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":401506.0,"PaymentsToAcquireRestrictedInvestments_3_Q3_USD":276000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PreferredStockSharesAuthorized_0_Q3_shares":1000000.0,"NetIncomeLoss_3_Q3_USD":-1516666.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockValue_0_Q3_USD":null,"PrepaidExpenseCurrent_0_Q3_USD":233323.0,"ProceedsFromInterestReceived_3_Q3_USD":0.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":270480000.0,"ProceedsFromIssuanceOfWarrants_3_Q3_USD":7520000.0,"ProceedsFromRelatedPartyDebt_3_Q3_USD":1000000.0,"ProceedsFromRepaymentsOfRelatedPartyDebt_3_Q3_USD":91306.0,"RedeemableNoncontrollingInterestEquityCommonCarryingAmount_0_Q3_USD":276000000.0,"RepaymentsOfRelatedPartyDebt_3_Q3_USD":136833.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-25635963.0,"SharePrice_0_Q3_USD":10.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"StockholdersEquity_0_Q3_USD":-25635273.0,"NetIncomeLoss_1_Q3_USD":5832363.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-276000000.0,"AdditionalPaidInCapital_0_Q3_USD":0.0,"Assets_0_Q3_USD":277027862.0,"AssetsCurrent_0_Q3_USD":1003976.0,"AssetsHeldInTrustNoncurrent_0_Q3_USD":276023886.0,"Cash_0_Q3_USD":770653.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":770653.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_3_Q3_USD":770653.0,"CashFDICInsuredAmount_0_Q3_USD":250000.0,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0_Q3_shares":14213333.0,"CommitmentsAndContingencies_0_Q3_USD":null,"DueToRelatedPartiesCurrent_0_Q3_USD":0.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-1782314.0,"FairValueAdjustmentOfWarrants_1_Q3_USD":-7533067.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":2867419.0,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":233323.0,"InvestmentIncomeInterest_1_Q3_USD":8147.0,"InvestmentIncomeInterest_3_Q3_USD":23886.0,"Liabilities_0_Q3_USD":26663135.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":277027862.0,"LiabilitiesAssumed1_3_Q3_USD":9660000.0,"LiabilitiesCurrent_0_Q3_USD":3500469.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q3_USD":-4595.0,"MarketableSecuritiesUnrealizedGainLoss_3_Q3_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":278552967.0,"FairValueAdjustmentOfWarrants_3_Q3_USD":-3126934.0,"TemporaryEquitySharesOutstanding_0_Q3_shares":27600000.0,"Ticker":"PEAR","CIK":"1835567","name":"THIMBLE POINT ACQUISITION CORP.","OfficialName":"Pear Therapeutics Inc. Class A Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"621640486.0","Country":"United States","Sector":"Technology","Industry":"Computer Software: Prepackaged Software","Market":"NASDAQ","SP500":"nan","filed":"20211105"}]